AT DARK HORSE CONSULTING, we work to accelerate cell and gene therapies through our unmatched expertise. Our consulting team has extensive CGT industry experience with knowledge spanning manufacturing, process development, comparability, analytical dev, quant modeling, quality systems, regulatory support, preclinical dev, device dev, program management, facility design and enginnering, market research, and due diligence and business strategy. 

Many of our consultants also bring experience from adjacent, more mature, sectors, including traditional biologics, small molecules, medical devices, and management consulting. Client requests range from scientific expertise to tactical needs to strategic considerations to business development. 

We understand the unique challenges faced by Cell and Gene Therapy developers like none other. We apply best practices from across this and other industries to address the needs of our clients, who range from biopharmaceutical companies to tools & tech providers to investment firms. 

Biotechnology

Life Sciences

Medical Devices

Dark Horse Consulting Group Inc.

Anthony Davies

Rachel Choate

John Yung

Sheryl Hancock-Andersen

Nathan Manley

Kimberly Benton

Sanjin Zvonić

Ebby Niyazi

The Quality and Regulatory Team at Dark Horse Consulting Group Inc. ensures that cell and gene therapies meet stringent quality and regulatory standards. This team offers expertise in the development and implementation of quality systems, guides clients through regulatory submissions, and ensures compliance with industry regulations to facilitate the successful approval and commercialization of innovative therapies.

Quality and Regulatory Team

Leadership Team

Principals and Heads

Business Operations Team

Quality and Regulatory Team

About

Team members

Other teams at Dark Horse Consulting Group Inc.

Leadership Team

Principals and Heads

Business Operations Team